Xianheng International Science & Technology (605056.SH) predicts a year-on-year increase in net profit for the 2024 fiscal year ranging from 86.25% to 148.34%.

Xianheng International Science&Technology (605056.SH) released its 2024 annual performance forecast, estimating a net profit attributable to shareholders of the listed company of 180 million to 240 million yuan in 2024, an increase of 83.36 million to 143.36 million yuan compared to the same period last year, an increase of 86.25% to 148.34% year-on-year. The main reasons for the increase in performance in this period: The company is a concentrated supplier for MRO, during the reporting period, the company continued to deepen its presence in the power grid sector, ensuring the foundation of performance while expanding into key strategic industries such as petroleum, petrochemicals, and power generation, achieving certain results. In 2023 and 2024, the company seized the opportunity of accelerated centralized procurement by central SOEs in the MRO industry, actively promoting its business in new fields such as energy and defense, leading to a significant increase in the company's revenue scale. To expand into new industry sectors, especially in 2023, the company made significant investments in digitalization, channel construction, staff deployment, and product development, leading to an increase in costs and expenses that had a somewhat adverse effect on the company's performance in 2023. During the reporting period, the company continued to invest in sales, technical services, research and development, and digitalization, but the management actively implemented the concept of "improving quality and efficiency", with year-on-year growth in revenue and efficiency per capita, driving strong growth in performance. In 2023, some trust products purchased by the company experienced delayed repayments, during the reporting period, the company's financial department, considering the latest progress of the relevant projects, tested the future repayment situation of the related financial products and further confirmed the fair value loss.